Join clinical development experts from IQVIA Biotech at booth #73 during Outsourcing in Clinical Trials New England, taking place October 27-28, 2026, at the Encore Boston Harbor in Boston, Massachusetts.

OCT New England brings together leaders from biotechnology companies, pharmaceutical organizations and clinical research partners to explore strategies for advancing oncology clinical development. Attendees will gain insights into today's most pressing challenges and emerging innovations in oncology operations, including clinical site engagement, data management, clinical supply strategy and evolving regulatory requirements.

While attending OCT New England, don't miss the opportunity to hear from Peter Ronco, President, IQVIA Biotech, who will present a featured session on predictive clinical development and participate in a panel discussion examining China's growing influence on global clinical development.

Featured IQVIA Biotech Sessions

• Tuesday, October 27 at 2:45 PM ET. "Predictive Clinical Development: De-Risking and Accelerating Clinical Development,” presented by Peter Ronco, President, IQVIA Biotech
• Wednesday, October 28 at 1:30 PM ET. “Biotech Power Shift: Navigating China’s Rise in Global Clinical Development,” panelists to include Peter Ronco, President, IQVIA Biotech

Visit IQVIA Biotech at booth #73 to discuss your clinical development strategy and learn how our global experts help emerging biopharma companies accelerate development while reducing risk. To schedule a meeting, visit our event website. For more information on IQVIA Biotech’s presence at OCT New England or to schedule a meeting with us, visit our event website.

Speaker:

Peter Ronco President, IQVIA Biotech